Variational AI
Founded in September 2019, Variational AI is a team of experienced AI and machine learning researchers, along with medicinal and computational chemists, applying state-of-the-art generative AI to drug discovery. Their platform, Enki™, enables the rapid generation of novel drug-like small molecules, significantly reducing the time and cost associated with traditional drug development methods. By collaborating closely with biopharmaceutical partners, Variational AI aims to redefine the unit economics of drug discovery and development, ultimately bringing new therapeutics to market across various disease areas.
Variational AI
Founded in September 2019, Variational AI is a team of experienced AI and machine learning researchers, along with medicinal and computational chemists, applying state-of-the-art generative AI to drug discovery. Their platform, Enki™, enables the rapid generation of novel drug-like small molecules, significantly reducing the time and cost associated with traditional drug development methods. By collaborating closely with biopharmaceutical partners, Variational AI aims to redefine the unit economics of drug discovery and development, ultimately bringing new therapeutics to market across various disease areas.